Researcher
Veerle SOMERS
- Keywords:Biomedical sciences (incl. biochemistry)
- Disciplines:Autoimmunity, General diagnostics, Adaptive immunology, Musculo-skeletal systems, Developmental neuroscience
Affiliations
- Immunology & Infection (Department)
Member
From1 Jan 2020 → Today - Immunology & Infection (Research group)
Member
From1 Jan 2020 → Today - Biomedical Research Institute (Research institute)
Member
From11 Dec 2003 → Today - Faculty of Medicine and Life Sciences (Faculty)
Member
From16 Jan 2003 → Today - Immunology - Biochemistry (Research group)
Member
From11 Dec 2003 → 31 Dec 2019 - Physiology - Biochemistry - Immunology (Department)
Member
From1 Oct 2003 → 31 Dec 2019 - Medical Basic Sciences (Division)
Member
From16 Jan 2003 → 30 Sep 2009
Projects
1 - 10 of 48
- Francqui Chair prof. dr. SwinnenFrom1 Oct 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Novel antibody biomarkers for the prediction of response to first-line therapy in rheumatoid arthritisFrom15 Jan 2023 → 14 Jan 2024Funding: IOF - technology concept exploration
- Spinal cord injury induced autoantibodies as biomarkers for patient stratificationFrom1 Nov 2022 → TodayFunding: FWO Strategic Basic Research Grant
- Anti-UH-RA antibody reactivity for prediction of response to first-line therapy in rheumatoid arthritis: validation in the independent CAP48 cohort.From1 Oct 2022 → 1 Dec 2023Funding: Foundations, funds and other with scientific goal
- Deep immune-phenotyping of multiple sclerosis patients using advanced spectral flow cytometryFrom1 Jan 2022 → 31 Dec 2023Funding: Foundations, funds and other with scientific goal
- The MIF-CD74 system as a driver of pro-inflammatory B cell responses following traumatic spinal cord injury (SCI).From1 Oct 2021 → TodayFunding: BOF - doctoral mandates
- Elucidating the role of double homeobox protein 4 (DUX4) in the pathology of inflammatory arthritisFrom1 Jan 2021 → 31 Dec 2021Funding: Foundations, funds and other with scientific goal
- Understanding how B cell depletion with ocrelizumab affects the immune system in the treatment of MSFrom1 Jan 2021 → 30 Jun 2023Funding: Foundations, funds and other with scientific goal
- Spinal cord injury induced autoantibodies as biomarkers for patient stratificationFrom1 Nov 2020 → 31 Oct 2022Funding: FWO Strategic Basic Research Grant
- Protective versus damaging aspects of the immune reaction in relation to clinical outcome in the Limburg COVID-19 cohortFrom15 Jun 2020 → 14 Jun 2022Funding: BOF - projects
Publications
101 - 110 of 127
- Citrulline-modified phage display: A novel high-throughput discovery approach for the identification of citrulline-containing ligands(2011)
Authors: Klaartje SOMERS, Piet STINISSEN, Veerle SOMERS
Pages: 2550 - 2554 - Characterization of the B cell response in Multiple Sclerosis and Clinically isolated syndrome using B cell immortalization(2011)
Authors: Judith FRAUSSEN, Veerle SOMERS, Marc DE BAETS
Number of pages: 173 - CX3CR1 DRIVES CD4+CD28NULL CYTOTOXIC T CELLS INTO THE CENTRAL NERVOUS SYSTEM OF MS PATIENTS(2011)
Authors: Niels HELLINGS, Bieke BROUX, Kim PANNEMANS, Xiaoe ZHANG, Silva Markovic-Plese, Tom BROEKMANS, Bert OP 'T EIJNDE, Veerle SOMERS, Piet GEUSENS, Piet STINISSEN
Pages: S139 - S139 - A novel method for making human monoclonal antibodies(2010)
Authors: Judith FRAUSSEN, K. Vrolix, Pilar Martinez-Martinez, M. Losen, E. Meulemans, Marc DE BAETS, Piet STINISSEN, Veerle SOMERS
Pages: 130 - 134 - Identification of novel potential antibody biomarkers in early multiple sclerosis(2010)
Authors: Myrthe ROUWETTE, Klaartje SOMERS, Cindy GOVARTS, Raymond Hupperts, Bart VAN WIJMEERSCH, Cees Zwanikken, Marcel Verbeek, Piet STINISSEN, Veerle SOMERS
Pages: 158 - 158 - The auto-antigen repertoire in myasthenia gravis(2010)
Authors: Kathleen Vrolix, Judith FRAUSSEN, Peter C. Molenaar, Mario Losen, Veerle SOMERS, Piet STINISSEN, Marc DE BAETS, Pilar Martinez-Martinez
Pages: 380 - 400 - Frameshifting in the P6 cDNA Phage Display System(2010)
Authors: Cindy GOVARTS, Klaartje SOMERS, Piet STINISSEN, Veerle SOMERS
Pages: 9380 - 9390 - Immortalized B cell lines from multiple sclerosis patients produce monoclonal autoreactive antibodies(2010)
Authors: Judith FRAUSSEN, Kathleen Vrolix, Pilar Martinez-Martinez, Mario Losen, Raymond Hupperts, Bart VAN WIJMEERSCH, Marc DE BAETS, Piet STINISSEN, Veerle SOMERS
Pages: 159 - 159 - CX3CR1 is a marker for senescent CD4+T cells and potentiates migration into the brain of Multiple Sclerosis patients(2010)
Authors: Bieke BROUX, Niels HELLINGS, Kim PANNEMANS, Tom BROEKMANS, Bert OP 'T EIJNDE, Bart VAN WIJMEERSCH, Veerle SOMERS, Piet GEUSENS, Piet STINISSEN
Pages: 118 - 118 - SPAG16 isoform 2 as a novel autoantigen in multiple sclerosis(2010)
Authors: Klaartje SOMERS, Jerome HENDRIKS, Raymond Hupperts, Cees Zwanikken, Marcel Verbeek, Piet STINISSEN, Veerle SOMERS
Pages: 162 - 162
Patents
1 - 9 of 9
- Method and means for diagnosis of spondyloarthritis (Inventor)
- Biomarkers for rheumatoid arthritis (Inventor)
- MEANS AND METHODS FOR THE DETERMINATION OF THE JOINT DESTRUCTION PROGRESSION RATE IN RHEUMATOID ARTHRITIS PATIENTS (Inventor)
- BIOMARKERS FOR MULTIPLE SCLEROSIS (Inventor)
- CITRULLINATION SPECIFIC PHAGE DISPLAY (Inventor)
- Biomarkers for rheumatoid arthritis (Inventor)
- CITRULLINATION SPECIFIC PHAGE DISPLAY (Inventor)
- Biomarkers for rheumatoid arthritis (Inventor)
- BIOMARKERS FOR RHEUMATOID ARTHRITIS (Inventor)
Linked dataset
1 - 1 of 1